Table 3.

Thrombotic risk and protein S levels according to the type of PROS1 gene defect

Splice-site or major structural defect Missense defectNormal
n  27  24  45  
Male, n (%) 9 (33.3)  10 (41.6)  21 (46.6) 
No. (%) with venous thromboembolism  13 (48.1) 9 (37.5)  3 (6.6)  
Total thrombotic events 26  15  4  
Years of follow-up  1187  1194  1713 
Median age at first thrombosis, y (range) 41.7 (17.1-69.5)  34.7 (20.1-58.9)  24.5 (20.4-35.7) 
Thromboses per 1000 person-years, median (range) 21.9 (14.3-32.0)  12.6 (7.0-20.7)  2.3 (0.6-6.0) 
Relative risk for thrombosis (95% CI)  6.3 (1.8-22.0) 4.3 (1.2-15.8)  1.0  
Total PS, mean (SD) in IU/mL 0.496 (0.13)  0.578 (0.08)  1.03 (0.18)  
Free PS, mean (SD) in IU/mL  0.196 (0.11)  0.349 (0.13) 1.07 (0.20) 
Splice-site or major structural defect Missense defectNormal
n  27  24  45  
Male, n (%) 9 (33.3)  10 (41.6)  21 (46.6) 
No. (%) with venous thromboembolism  13 (48.1) 9 (37.5)  3 (6.6)  
Total thrombotic events 26  15  4  
Years of follow-up  1187  1194  1713 
Median age at first thrombosis, y (range) 41.7 (17.1-69.5)  34.7 (20.1-58.9)  24.5 (20.4-35.7) 
Thromboses per 1000 person-years, median (range) 21.9 (14.3-32.0)  12.6 (7.0-20.7)  2.3 (0.6-6.0) 
Relative risk for thrombosis (95% CI)  6.3 (1.8-22.0) 4.3 (1.2-15.8)  1.0  
Total PS, mean (SD) in IU/mL 0.496 (0.13)  0.578 (0.08)  1.03 (0.18)  
Free PS, mean (SD) in IU/mL  0.196 (0.11)  0.349 (0.13) 1.07 (0.20) 

Patients with other thrombophilic defects were excluded. Relative risk is compared with that of relatives with a normal PROS1gene.

Close Modal

or Create an Account

Close Modal
Close Modal